Menu
GWAS Study

Genome-wide association study identifies novel loci predisposing to cutaneous melanoma.

Amos CI, Wang LE, Lee JE et al.

21926416 PubMed ID
GWAS Study Type
32637 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

AC
Amos CI
WL
Wang LE
LJ
Lee JE
GJ
Gershenwald JE
CW
Chen WV
FS
Fang S
KR
Kosoy R
ZM
Zhang M
QA
Qureshi AA
VS
Vattathil S
SC
Schacherer CW
GJ
Gardner JM
WY
Wang Y
BD
Bishop DT
BJ
Barrett JH
MS
MacGregor S
HN
Hayward NK
MN
Martin NG
DD
Duffy DL
MG
Mann GJ
CA
Cust A
HJ
Hopper J
BK
Brown KM
GE
Grimm EA
XY
Xu Y
HY
Han Y
JK
Jing K
MC
McHugh C
LC
Laurie CC
DK
Doheny KF
PE
Pugh EW
SM
Seldin MF
HJ
Han J
WQ
Wei Q
Chapter II

Abstract

Summary of the research findings

We performed a multistage genome-wide association study of melanoma. In a discovery cohort of 1804 melanoma cases and 1026 controls, we identified loci at chromosomes 15q13.1 (HERC2/OCA2 region) and 16q24.3 (MC1R) regions that reached genome-wide significance within this study and also found strong evidence for genetic effects on susceptibility to melanoma from markers on chromosome 9p21.3 in the p16/ARF region and on chromosome 1q21.3 (ARNT/LASS2/ANXA9 region). The most significant single-nucleotide polymorphisms (SNPs) in the 15q13.1 locus (rs1129038 and rs12913832) lie within a genomic region that has profound effects on eye and skin color; notably, 50% of variability in eye color is associated with variation in the SNP rs12913832. Because eye and skin colors vary across European populations, we further evaluated the associations of the significant SNPs after carefully adjusting for European substructure. We also evaluated the top 10 most significant SNPs by using data from three other genome-wide scans. Additional in silico data provided replication of the findings from the most significant region on chromosome 1q21.3 rs7412746 (P = 6 × 10(-10)). Together, these data identified several candidate genes for additional studies to identify causal variants predisposing to increased risk for developing melanoma.

1,804 European ancestry cases, 1,026 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

32637
Total Participants
GWAS
Study Type
Yes
Replicated
6,483 European and Middle East/North African ancestry cases, 23,324 European and Middle East/North African ancestry controls
Replication Participants
European, European, Greater Middle Eastern (Middle Eastern, North African or Persian)
Ancestry
U.S., Israel, Australia, France
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.